Cyclosporin A inhibits hepatitis C virus replication and restores interferon‐alpha expression in hepatocytes

J.‐P. Liu, L. Ye, X. Wang, J.‐L. Li, W.‐Z. Ho. Cyclosporin A inhibits hepatitis C virus replication and restores interferon‐alpha expression in hepatocytes.
Transpl Infect Dis 2011: 13: 24–32. All rights reserved

[1]  I. Hutchinson,et al.  Impact of Hepatitis C Infection on Outcomes After Heart Transplantation , 2009, Transplantation.

[2]  Ralf Bartenschlager,et al.  Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A , 2009, Hepatology.

[3]  Lin Zhou,et al.  CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes , 2009, Hepatology.

[4]  A. Osuna,et al.  Hepatitis C virus infection after renal transplantation. , 2008, Transplantation Proceedings.

[5]  Feng Yang,et al.  Cyclophilin A Is an Essential Cofactor for Hepatitis C Virus Infection and the Principal Mediator of Cyclosporine Resistance In Vitro , 2008, Journal of Virology.

[6]  N. Kato,et al.  Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon‐induced antiviral protein in human hepatocyte cells , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[7]  L. Rostaing,et al.  Alpha-interferon therapy for chronic hepatitis C may induce acute allograft rejection in kidney transplant patients with failed allografts. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  Stefano Volinia,et al.  Interferon modulation of cellular microRNAs as an antiviral mechanism , 2007, Nature.

[9]  W. Ho,et al.  Morphine inhibits intrahepatic interferon- alpha expression and enhances complete hepatitis C virus replication. , 2007, The Journal of infectious diseases.

[10]  F. Chisari,et al.  Differential Biophysical Properties of Infectious Intracellular and Secreted Hepatitis C Virus Particles , 2006, Journal of Virology.

[11]  K. Abbott,et al.  Acute Renal Allograft Rejection Following Pegylated IFN‐α Treatment for Chronic HCV in a Repeat Allograft Recipient on Hemodialysis: A Case Report , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[12]  K. Shuai,et al.  Regulation of cytokine signaling pathways by PIAS proteins , 2006, Cell Research.

[13]  W. Ho,et al.  Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines , 2005, Hepatology.

[14]  P. Sarnow,et al.  Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA , 2005, Science.

[15]  N. Enomoto,et al.  Suppression of hepatitis C virus replication by cyclosporin a is mediated by blockade of cyclophilins. , 2005, Gastroenterology.

[16]  Toshiaki Maruyama,et al.  Complete Replication of Hepatitis C Virus in Cell Culture , 2005, Science.

[17]  R. Bartenschlager,et al.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome , 2005, Nature Medicine.

[18]  D. Burton,et al.  Robust hepatitis C virus infection in vitro. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  K. Inoue,et al.  Interferon combined with cyclosporine treatment as an effective countermeasure against hepatitis C virus recurrence in liver transplant patients with end-stage hepatitis C virus related disease. , 2005, Transplantation proceedings.

[20]  J. Orange,et al.  Natural killer cells inhibit hepatitis C virus expression , 2004, Journal of leukocyte biology.

[21]  P. Keskinen,et al.  Expression of hepatitis C virus core protein inhibits interferon‐induced nuclear import of STATs , 2004, Journal of medical virology.

[22]  F. Kopp,et al.  SOCS-1 and SOCS-3 inhibit IFN-α-induced expression of the antiviral proteins 2,5-OAS and MxA , 2004 .

[23]  J. McHutchison,et al.  Initial treatment for chronic hepatitis C: current therapies and their optimal dosing and duration. , 2004, Cleveland Clinic journal of medicine.

[24]  E. Tuzcu,et al.  Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[25]  N. Enomoto,et al.  Specific inhibition of hepatitis C virus replication by cyclosporin A. , 2004, Biochemical and biophysical research communications.

[26]  F. Kopp,et al.  SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA. , 2004, Biochemical and biophysical research communications.

[27]  B. Bacon.  Treatment for chronic hepatitis C , 2003, Current gastroenterology reports.

[28]  Tsunamasa Watanabe,et al.  Combined interferon alpha2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial. , 2003, Journal of gastroenterology.

[29]  Tsunamasa Watanabe,et al.  Combined interferon α2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial , 2003, Journal of Gastroenterology.

[30]  F. Fabrizi,et al.  Hepatitis C infection and the patient with end‐stage renal disease , 2002, Hepatology.

[31]  D. Metzger,et al.  Real-time RT-PCR for quantitation of hepatitis C virus RNA. , 2002, Journal of virological methods.

[32]  V. Mas,et al.  Hepatitis C virus infection after renal transplantation: viral load and outcome. , 2001, Transplantation proceedings.

[33]  F. McKeon,et al.  NF-AT activation requires suppression of Crm1-dependent export by calcineurin , 1999, Nature.

[34]  P Jay,et al.  Specific inhibition of Stat3 signal transduction by PIAS3. , 1997, Science.

[35]  M. Kohara,et al.  Effects of cyclosporin A on hepatitis C virus infection in bone marrow transplant patients , 1997, Bone Marrow Transplantation.

[36]  W. Trommer,et al.  Cyclosporine A-induced oxidative stress in rat hepatocytes. , 1997, The Journal of pharmacology and experimental therapeutics.

[37]  J. Pawlotsky,et al.  Factors Affecting Treatment Responses to Interferon-α in Chronic Hepatitis C , 1996 .

[38]  R. Adkins,et al.  Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. , 1994, Gastroenterology.